Differential (Click to cross reference) adverse drug reaction algorithm andexanet anticoagulant, complications of anticoagulant, discontinuation anticoagulant, reversal of anticoagulant, treatment apixaban cerebrospinal fluid ciraparantag coagulopathy complications controversies in neurology cost cost effectiveness coumarin dabigatran efficacy emergencies, neurologic facial nerve palsy factor Xa inhibitor fresh frozen plasma heart valve, prosthetic hemostatic therapy idarucizumab INR values intracerebral hemorrhage intracerebral hemorrhage, progression of intracerebral hemorrhage, volume mortality non-vitamin K antagonist oral anticoagulants practice guidelines prothrombin complex concentrate review article safety treatment of neurologic disorder vitamin K

Showing articles 0 to 8 of 8 Economic Evaluation of Andexanet Versus Prothrombin Complex Concentrate for Reversal of Factor Xa-Associated Intracranial Hemorrhage Stroke 52:1390-1397, Micieli, A.,et al, 2021 Contemporary Reversal of Oral Anticoagulation in Intracerebral Hemorrhage Stroke 50:529-536, Bower, M.M.,et al, 2019 Management of Bleeding in Patients Taking Oral Anticoagulants JAMA 319:2032-2033, Anderson, I.,et al, 2018 Anticoagulant-Associated Intracranial Hemorrhage in the Era of Reversal Agents Stroke 48:1432-1437, Steiner, T.,et al, 2017 Hemostatic Therapy Should be Used for Acute Treatment of Anticoagulation-Related Intracerebral Hemorrhage Stroke 43:2535-2536,2539, Diringer, M. & Zazulia, A.R., 2012 Hemostatic Therapy Should not be Used for Acute Treatment of Anticoagulation-Related Intracerebral Hemorrhage Stroke 43:2537-2538,2539, Stapf, C., 2012 Intracerebral Hemorrhage Associated with Oral Anticoagulant Therapy Stroke 37:256-262, Steiner, T.,et al, 2006 Emergency Reversal of Anticoagulation aftr Intracerebral Hemorrhage Stroke 23:972-977, Fredriksson,K.,et al, 1992 Showing articles 0 to 8 of 8